Key result
Site-directed mutagenesis of lysine 65 in human CRP1 led to a 10-fold decrease in alpha-actinin binding compared with wild-type CRP, mapping the binding site to an 18-residue sequence.
Effect estimate: 10-fold decrease
The alpha-actinin-binding region of CRP is confined to an 18-residue sequence in the N-terminal glycine-rich repeat, with lysine 65 being a critical structural element for this interaction.
No immediate clinical impact; leaves open the physiological role of this interaction in cardiovascular models.
The cysteine-rich proteins (CRPs) are a family of highly conserved LIM (an acronym derived from the three gene products lin-11, isl-1 and mec-3) domain proteins that have been implicated in muscle differentiation. All CRP family members characterized so far have been shown to interact with the filamentous actin cross-linker alpha-actinin. The region of CRP required for this interaction has previously been broadly mapped to the molecule's N-terminal half. Here we report that the alpha-actinin-binding region of CRP, which we have mapped by using a combination of blot overlay and Western immunoblot techniques, is confined to an 18-residue sequence occurring within the protein's N-terminal glycine-rich repeat. A site-directed mutagenesis analysis of the binding region has revealed the critical importance of a single lysine residue (lysine 65 in human CRP1). Alterations at this site lead to a 10-fold decrease in alpha-actinin binding in comparison with wild-type CRP. The critical lysine residue localizes within a short alpha-helix, raising the possibility that mutagenesis-induced alterations in alpha-actinin-binding capacity might be attributed to the disruption of a key structural element.
No takes yet. Share an insight, caveat, or question.
HARPER et al. (2000) studied this question. Site-directed mutagenesis of CRP vs. Wild-type CRP was evaluated on alpha-actinin binding capacity (10-fold decrease). Site-directed mutagenesis of lysine 65 in human CRP1 led to a 10-fold decrease in alpha-actinin binding compared with wild-type CRP, mapping the binding site to an 18-residue sequence.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: